On the other hand, the predictive signature in men, cluster label mc5, was not associated with IDH1 mutations, which was supported by the REMBRANDT diagnosis distribution being strongly weighted towards GBM, a disease identified by its association with the wildtype IDH1 status. Here, IDH1 is linked to glioblastoma.